Showing results (461-470 of 1,350) with videos related to

Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|April 30, 2016
Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on C-peptide kineticsDavid Polidori, Sue Sha, Tim Heise, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
The effects of CYP3A4 induction and inhibition on the pharmacokinetics of alisporivir in humansAvantika Barve, Steven J Kovacs, June Ke, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Vorapaxar, an oral PAR-1 receptor antagonist, does not affect the pharmacokinetics of rosiglitazoneTeddy Kosoglou, Bharath Kumar, Paul Statkevich, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinonePeter H Langsjoen, Alena M Langsjoen
Clinical Pharmacology in Drug Development|April 30, 2016
A single and multiple dose study to investigate the pharmacokinetics of a prolonged release formulation of ropinirole in healthy Chinese subjectsHongzhong Liu, Ji Jiang, Hongyun Wang, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Effect of food and gemfibrozil on the pharmacokinetics of the novel prolyl hydroxylase inhibitor GSK1278863Brendan M Johnson, Brendt A Stier, Stephen Caltabiano
Clinical Pharmacology in Drug Development|April 30, 2016
The effect of food on the pharmacokinetics of tivozanib hydrochlorideMonette M Cotreau, Lisa Massmanian, Andrew L Strahs, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
No influence of the CYP2C19-selective inhibitor omeprazole on the pharmacokinetics of the dopamine receptor agonist rotigotineJan-Peer Elshoff, Willi Cawello, Jens-Otto Andreas, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Evaluation of the effect of ruxolitinib on cardiac repolarization: A thorough QT studyNaresh Punwani, Swamy Yeleswaram, Xuejun Chen, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
A double-blind, randomized, ascending, multiple-dose study of bazedoxifene in healthy postmenopausal womenWilliam E McKeand, Gayle P Orczyk, James C Ermer, et al.
Pageof 135